Clopidogrel Genotyping in Primary PCI: A Cautious AdvanceClopidogrel Genotyping in Primary PCI: A Cautious Advance

In a rare clinical trial, genotyping for clopidogrel loss of function seemed to guide antiplatelet changes when they were most needed; but was it the genotyping assay that made the difference? Heartwire
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news